Wanhong Lu

896 total citations
35 papers, 509 citations indexed

About

Wanhong Lu is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wanhong Lu has authored 35 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nephrology, 9 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wanhong Lu's work include Renal Diseases and Glomerulopathies (11 papers), Dialysis and Renal Disease Management (9 papers) and Chronic Kidney Disease and Diabetes (4 papers). Wanhong Lu is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Dialysis and Renal Disease Management (9 papers) and Chronic Kidney Disease and Diabetes (4 papers). Wanhong Lu collaborates with scholars based in China, United States and Hong Kong. Wanhong Lu's co-authors include Huixian Li, Liyi Xie, Hongli Jiang, Ani Wang, Jun Lyu, Darko Stefanović, Yang Li, Joanne Macdonald, Milan N. Stojanović and Jie Feng and has published in prestigious journals such as Nano Letters, PLoS ONE and Scientific Reports.

In The Last Decade

Wanhong Lu

31 papers receiving 507 citations

Peers

Wanhong Lu
Claudia Pontillo Germany
Berthil H.C.M.T. Prinsen Netherlands
Benjamin Breuil France
Qingqing Cai China
Frank Dellanna Germany
Hiroki Ishii Japan
Emmanuel Estève France
Ronald Krebs Germany
Yongguang Liu China
Claudia Pontillo Germany
Wanhong Lu
Citations per year, relative to Wanhong Lu Wanhong Lu (= 1×) peers Claudia Pontillo

Countries citing papers authored by Wanhong Lu

Since Specialization
Citations

This map shows the geographic impact of Wanhong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanhong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanhong Lu more than expected).

Fields of papers citing papers by Wanhong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanhong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanhong Lu. The network helps show where Wanhong Lu may publish in the future.

Co-authorship network of co-authors of Wanhong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanhong Lu. A scholar is included among the top collaborators of Wanhong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanhong Lu. Wanhong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huixian, Jing Li, Xinfang Xie, et al.. (2025). Additive Obinutuzumab Achieves High Remission Rates in Rituximab-Refractory Membranous Nephropathy. American Journal of Nephrology. 57(1). 21–29.
2.
Sun, Xuefeng, Li Zhang, Hongli Lin, et al.. (2025). Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia. Kidney International Reports. 10(4). 1050–1062. 1 indexed citations
3.
4.
Li, Huixian, Xiaoling Liu, Haiyun Li, et al.. (2024). Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy. Frontiers in Immunology. 15. 1415026–1415026. 5 indexed citations
5.
6.
Xie, Liyi, et al.. (2024). Hyperactivation of p53 contributes to mitotic catastrophe in podocytes through regulation of the Wee1/CDK1/cyclin B1 axis. Renal Failure. 46(2). 2365408–2365408. 4 indexed citations
7.
Xie, Xinfang, et al.. (2023). The association of serum anti-PLA2R antibody and glomerular PLA2R antigen staining with clinical manifestations and outcomes in membranous nephropathy. Clinical and Experimental Nephrology. 27(12). 1060–1066. 1 indexed citations
8.
Lu, Wanhong, et al.. (2023). Factors Associated with Dialysis Initiation in Patients with Predialysis Arteriovenous Fistula. Blood Purification. 53(3). 210–218.
9.
Li, Philip Kam‐Tao, Wanhong Lu, Siu‐Ka Mak, et al.. (2022). Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology. 27(10). 787–794. 26 indexed citations
10.
Li, Huixian, Xiaoyang Yu, Zhigang Wang, et al.. (2022). Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences. International Urology and Nephrology. 54(10). 2609–2616. 8 indexed citations
11.
Li, Yan, Xiaoyang Yu, Wenjing Zhang, et al.. (2022). Epidemiological characteristics and pathological changes of primary glomerular diseases. PLoS ONE. 17(8). e0272237–e0272237. 5 indexed citations
12.
Xie, Xinfang, Pan Liu, Jicheng Lv, et al.. (2021). Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine. JCI Insight. 6(19). 7 indexed citations
13.
Li, Huixian, Wanhong Lu, Haiyun Li, et al.. (2021). Immune Characteristics of IgA Nephropathy With Minimal Change Disease. Frontiers in Pharmacology. 12. 793511–793511. 8 indexed citations
14.
Feng, Jie, Liyi Xie, Xiaoyang Yu, et al.. (2021). Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation. Biochemical and Biophysical Research Communications. 544. 22–30. 23 indexed citations
15.
Feng, Jie, Bao Li, Xuan Wang, et al.. (2020). Low expression of HIV genes in podocytes accelerates the progression of diabetic kidney disease in mice. Kidney International. 99(4). 914–925. 22 indexed citations
16.
Sun, Jiping, et al.. (2020). MiR‐325‐3p inhibits renal inflammation and fibrosis by targeting CCL19 in diabetic nephropathy. Clinical and Experimental Pharmacology and Physiology. 47(11). 1850–1860. 24 indexed citations
17.
Li, Huixian, et al.. (2019). Peritoneal Dialysis Treatment in Small Children with Acute Kidney Injury: Experience in Northwest China. Blood Purification. 48(4). 315–320. 5 indexed citations
18.
Wang, Jing, et al.. (2019). Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. Biochemical and Biophysical Research Communications. 516(3). 858–865. 22 indexed citations
19.
Lu, Wanhong, Wing‐Fai Pang, Huixian Li, et al.. (2018). Peritoneal protein clearance predicts mortality in peritoneal dialysis patients. Clinical and Experimental Nephrology. 23(4). 551–560. 17 indexed citations
20.
Niu, Dan, Ya Gao, Liyi Xie, et al.. (2015). Genetic polymorphisms in TNFSF13 and FDX1 are associated with IgA nephropathy in the Han Chinese population. Human Immunology. 76(11). 831–835. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Pontillo Breakdown of academic impact, for papers by Berthil H.C.M.T. Prinsen Breakdown of academic impact, for papers by Benjamin Breuil Breakdown of academic impact, for papers by Qingqing Cai Breakdown of academic impact, for papers by Frank Dellanna Breakdown of academic impact, for papers by Hiroki Ishii Breakdown of academic impact, for papers by Emmanuel Estève Breakdown of academic impact, for papers by Ronald Krebs Breakdown of academic impact, for papers by Yongguang Liu
Rankless by CCL
2026